-+ 0.00%
-+ 0.00%
-+ 0.00%

Lakefront Biotherapeutics Launches Share Buyback of Up to €50 Million

PUBT·11/16/2026 06:32:12
Lakefront Biotherapeutics Launches Share Buyback of Up to €50 Million
  • Lakefront Biotherapeutics launched a new share buyback of up to €50 million on November 16, 2026.
  • The program covers up to 4,604,550 ordinary shares and ends March 31, 2027, or earlier upon completion of the mandate.
  • The initial €50 million buyback concluded October 16, 2026, with approximately 1,990,000 ordinary shares repurchased.
  • Repurchased shares will be held as treasury shares for potential use in equity-based incentive programs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lakefront Biotherapeutics NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160130PRIMZONEFULLFEED1001303548) on November 16, 2026, and is solely responsible for the information contained therein.